Yang(K),Luo(H),Xiang(B),Dai(Y),Gong(Y),Hua... Cancer Med 2026-09-00

...ELN 2022 risk category and age. Sensitivity analyses accounting for stem cell transplantation and untreated patients yie...

Hernández-Sánchez(A),Martínez Elicegui(J),... Hemasphere 2026-09-00

...ELN)2022 risk classification in estimating 5-year overall survival (0.741 vs. 0.700), 5-year relapse-free survival (0.75...

Reeves(BN),El Chaer(F),Foltz(L),Tashi(T),A... Lancet Reg Health Am 2026-09-00

...ELN) response at both Months 10 and 13 (ClinicalTrials.gov identifier: NCT05482971). Between January 17, 2023, and May 1...

Bhat(AA),Fuloria(S),Thapa(R),Narain(K),Bha... Clin Chim Acta 2026-06-17

...ELN-based risk stratification, acute myeloid leukemia (AML) still faces three significant challenges: relapse, resistanc...

Krayem(B),Biswas(J),Derkach(A),Rafizadeh(M... Blood Adv 2026-09-08

...ELN) 2022 risk category, and induction regimen. Pediatric patients received 2 cycles of cytarabine, daunorubicin, and et...

Liao(Y),Zhang(H),Huang(Z),Mo(L),Wu(Z),Zhou... Curr Res Food Sci None

...ELNs (ARELNs) exhibited the most potent and broad-spectrum inhibitory activity, reducing total HAs by 53.4% and total AG...

Heuser(M),Wickenhauser(C),Oevel(L),Bauer(M... Pathologie (Heidelb) 2026-07-00

...ELN) recommendations for the first time established a widely accepted framework for minimum technical standards and repo...

Lv(M),Ding(W),Zhou(M),Xiang(T),Zhang(D) Biochem Biophys Res Commun 2026-09-03

...ELNs. This study identifies miR-396b as a major functional cargo of T. hemsleyanum-derived ELNs and demonstrates that EL...

Dalle(IA),Galimard(JE),Bazarbachi(A),De La... Haematologica 2026-06-25

...ELN) 2022 classification categorized both t(9;11)(p21.3;q23.3) and isolated del(7q) in acute myeloid leukemia (AML) as i...

Milojkovic(D),Cross(NCP),Desai(K),Frewin(K... Eur J Haematol 2026-06-25

...ELN) 2020 response was rare (10% vs. 56% in patients with > 1 warning response and 100% in failure response). BCR::ABL1 ...